A Phase 2 Clinical Study of ABSK061 and ABSK043

Clinical trial NCT06632262 · RECRUITING

Trial details

NCT number: NCT06632262
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-Gastric/Gastroesophageal Junction Cancer Urothelial Carcinoma Non-Small Cell Lung Cancer Solid Tumors

Start date: 2024-11-13
Primary completion: 2029-11-30
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.